Howe & Rusling Inc Regeneron Pharmaceuticals, Inc. Transaction History

Howe & Rusling Inc

$1.16 Billion
Q3 2024

A detailed history of Howe & Rusling Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Howe & Rusling Inc holds 462 shares of REGN stock, worth $348,749. This represents 0.04% of its overall portfolio holdings.

Number of Shares

462

Previous 447 3.36%

Holding current value

$348,749

Previous $469,000 3.41%

% of portfolio

0.04%

Previous 0.04%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$1024.09 - $1201.76 $15,361 - $18,026	15 Added 3.36%	462 $485,000
Q2 2024 Aug 13, 2024	BUY	$883.2 - $1071.19 $31,795 - $38,562	36 Added 8.76%	447 $469,000
Q1 2024 May 15, 2024	SELL	$902.69 - $993.35 $38,815 - $42,714	-43 Reduced 9.47%	411 $395,000
Q4 2023 Feb 05, 2024	BUY	$775.18 - $881.7 $6,976 - $7,935	9 Added 2.02%	454 $398,000
Q3 2023 Nov 08, 2023	BUY	$692.45 - $844.37 $4,847 - $5,910	7 Added 1.6%	445 $366,000
Q4 2021 Feb 14, 2022	SELL	$543.48 - $670.97 $543 - $670	-1 Reduced 0.23%	438 $277,000
Q3 2021 Nov 15, 2021	BUY	$574.03 - $680.96 $574 - $680	1 Added 0.23%	439 $266,000
Q1 2021 May 13, 2021	BUY	$446.73 - $548.2 $78,177 - $95,935	175 Added 66.54%	438 $207,000
Q3 2020 Nov 06, 2020	BUY	$544.75 - $658.21 $9,805 - $11,847	18 Added 7.35%	263 $147,000
Q4 2019 Feb 05, 2020	BUY	$274.13 - $376.51 $67,161 - $92,244	245 New	245 $92,000
Q4 2018 Feb 04, 2019	SELL	$335.82 - $403.04 $8,395 - $10,076	-25 Closed	0 $0
Q3 2018 Nov 07, 2018	BUY	$351.14 - $408.51 $8,778 - $10,212	25 New	25 $10,000
Q2 2018 Jul 31, 2018	SELL	$284.6 - $344.99 $11,384 - $13,799	-40 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$315.82 - $393.78 $11,053 - $13,782	35 Added 700.0%	40 $14,000
Q3 2017 Oct 18, 2017	BUY	$431.38 - $504.0 $2,156 - $2,520	5	5 $2,000

Others Institutions Holding REGN

# of Institutions

1,532

Shares Held

83.8M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $80.9B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Howe & Rusling Inc, based on Form 13F filings with the SEC.

News

Stay updated on Howe & Rusling Inc with notifications on news.

Account